Risk Mitigation Pivotal To Starting Clinical Trials
Source: Oracle Health Sciences

While risk management efforts in drug development have focused mostly on post-marketing drug safety, the clinical trials process has its own mix of potential risks just waiting to derail a company’s high dollar development programs. These risks include patient enrollment issues, site staffing shortages, logistical problems with drug supplies, and regulatory delays. Moreover, risk-based challenges are escalating as clinical trials become more global and complex, and as market pressures keep rising for new therapies at an ever-increasing pace.
VIEW THE ARTICLE!
Log In
Signing up provides unlimited access to:
Free Sign Up

Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of Clinical Leader? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
Oracle Health Sciences
This website uses cookies to ensure you get the best experience on our website. Learn more